Low-grade EECs were typically diagnosed at early FIGO stages and were more likely to exhibit favorable biomarker profiles, including strong ER and PR expression, PTEN retention, and MMR deficiency. This evidence concerns the gene PTEN and mismatch repair cancer syndrome 1.